BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$344M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$266M |
| 3 |
Motorola Solutions
MSI
|
+$224M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$222M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$235M |
| 2 |
Alibaba
BABA
|
+$199M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$195M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$132M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.41% |
| 2 | Financials | 6.99% |
| 3 | Consumer Discretionary | 5.47% |
| 4 | Healthcare | 5.09% |
| 5 | Industrials | 4.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Tejon Ranch
TRC
$442M
| $1.08M | ﹤0.01% |
63,710
+415
| +0.7% | +$7.23K |
|
1702
CALL
BP
BP
$110B
| $1.08M | ﹤0.01% |
284
-5
| -2% | -$191 |
|
1703
PUT
FIVE9
FIVN
$2.47B
| $1.07M | ﹤0.01% |
+200
| New | +$11.3K |
|
|
CONN
1704
DELISTED
Conn's Inc.
CONN
| $1.07M | ﹤0.01% |
43,138
+940
| +2% | +$19.8K |
|
1705
Mercury Insurance
MCY
$5.82B
| $1.07M | ﹤0.01% |
19,155
-6,169
| -24% | -$353K |
|
1706
Teladoc Health
TDOC
$1.25B
| $1.07M | ﹤0.01% |
15,753
+5,936
| +60% | +$391K |
|
1707
First Hawaiian
FHB
$3.39B
| $1.07M | ﹤0.01% |
39,937
-75,212
| -65% | -$1.95M |
|
1708
Wyndham Hotels & Resorts
WH
$5.48B
| $1.07M | ﹤0.01% |
20,604
+13,067
| +173% | +$714K |
|
1709
Restaurant Brands International
QSR
$26.9B
| $1.07M | ﹤0.01% |
14,973
+14,083
| +1,582% | +$1.04M |
|
|
DOC
1710
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $1.06M | ﹤0.01% |
59,933
+33,158
| +124% | +$576K |
|
1711
Ormat Technologies
ORA
$7.05B
| $1.06M | ﹤0.01% |
14,310
+892
| +7% | +$61.5K |
|
1712
PUT
Vodafone
VOD
$37.9B
| $1.06M | ﹤0.01% |
533
-47
| -8% | -$852 |
|
1713
Webster Financial
WBS
$12.8B
| $1.05M | ﹤0.01% |
22,463
+4,314
| +24% | +$204K |
|
1714
PUT
Freeport-McMoran
FCX
$93.5B
| $1.05M | ﹤0.01% |
1,100
-400
| -27% | -$4.11K |
|
1715
Woodward
WWD
$21.6B
| $1.05M | ﹤0.01% |
9,750
+2,616
| +37% | +$288K |
|
1716
Cracker Barrel
CBRL
$1.27B
| $1.04M | ﹤0.01% |
6,400
+2,204
| +53% | +$371K |
|
1717
PUT
Analog Devices
ADI
$187B
| $1.04M | ﹤0.01% |
93
| – | – |
|
1718
PUT
Teva Pharmaceuticals
TEVA
$42.5B
| $1.03M | ﹤0.01% |
1,500
-1,766
| -54% | -$13.5K |
|
1719
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$43.8B
| $1.03M | ﹤0.01% |
114
| – | – |
|
1720
Box
BOX
$4.57B
| $1.02M | ﹤0.01% |
61,619
+10,696
| +21% | +$172K |
|
|
PDCE
1721
DELISTED
PDC Energy, Inc.
PDCE
| $1.02M | ﹤0.01% |
36,659
+6,545
| +22% | +$196K |
|
1722
CRISPR Therapeutics
CRSP
$5.13B
| $1.02M | ﹤0.01% |
24,782
+23,911
| +2,745% | +$1.14M |
|
1723
Trex
TREX
$5.06B
| $1.01M | ﹤0.01% |
22,320
+10,156
| +83% | +$410K |
|
1724
MGE Energy Inc
MGEE
$3.09B
| $1.01M | ﹤0.01% |
12,692
-4,686
| -27% | -$350K |
|
|
PFPT
1725
DELISTED
Proofpoint, Inc.
PFPT
| $1.01M | ﹤0.01% |
7,851
-15,497
| -66% | -$1.9M |
|
Similar funds
BNP Paribas Financial Markets's Q3 2019 Portfolio in Review
As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.6% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $235M trimmed.
- BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
- BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
- BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
- BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
- BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.